Brain Stimulation Shows Promise for Autism Symptoms, as Researchers Seek Better Definitions for Profound Autism

Personalized Brain Stimulation Shows Early Promise A double-blind, randomized controlled trial published in Molecular Psychiatry in April 2026 found that accelerated intermittent theta burst stimulation (aiTBS), when precisely targeted to an individual’s fronto-parietal control network, significantly improved core autism symptoms like social communication and repetitive behaviors. The study involved 78 autistic participants aged 14-30, with those receiving real stimulation showing greater improvements than the placebo group after 10 sessions. While promising, the authors caution that larger trials are needed to confirm effects and optimize protocols.

The Challenge of Defining 'Profound Autism' Concurrently, a systematic review in Molecular Autism highlights how inconsistent definitions of 'profound autism' — often referring to individuals with intellectual disability, minimal verbal ability, or high support needs — leave this population underrepresented in research. The review proposes standardized criteria to ensure studies include nonverbal and minimally verbal participants, who comprise an estimated 25-30% of autistic people but are rarely included in intervention trials. Advocates argue this gap perpetuates inequities in access to tailored supports.

The study involved 78 autistic participants aged 14-30, with those receiving real stimulation showing greater improvements than the placebo group after 10 sessions.

Behavioral Interventions Remain Key The review also reinforces consensus that early, evidence-based behavioral interventions (like speech therapy or AAC training) can support language development in nonspeaking children, though outcomes vary widely. It warns against debunked methods like facilitated communication, which multiple studies have shown to be ineffective and potentially harmful.